Canine Leishmaniasis in North America: Emerging or Newly Recognized?

Veterinary Clinics of North America - Small Animal Practice

Volumn 39, Issue 6, 2009, Pages 1065-1074

  Petersen, Christine A ^a   Barr, Stephen C ^b  

^a IOWA STATE UNIVERSITY   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

Canine; Diagnosis; Emerging; Leishmania infantum; Protozoa; Treatment

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; HUMANTIN; MEGLUMINE ANTIMONATE; PAROMOMYCIN; STIBOGLUCONATE SODIUM; UNCLASSIFIED DRUG;

CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE TRANSMISSION; DOG DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC SUSCEPTIBILITY; IMMUNOPATHOLOGY; LEISHMANIA INFANTUM; NONHUMAN; NORTH AMERICA; PARASITE VECTOR; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; REVIEW; RISK FACTOR; VERTICAL TRANSMISSION; VISCERAL LEISHMANIASIS;

ANIMALS; COMMUNICABLE DISEASES, EMERGING; DEMOGRAPHY; DOG DISEASES; DOGS; ENDEMIC DISEASES; INSECT VECTORS; LEISHMANIASIS; NORTH AMERICA; PSYCHODIDAE;

LEISHMANIA INFANTUM; PROTOZOA;

EID: 71849110317     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2009.06.008     Document Type: Review

References (24)

1. Roberts L.J., Handman E., and Foote S.J. Science, medicine, and the future: Leishmaniasis. BMJ 321 7264 (2000) 801-804
2. Gavgani A.S., Hodjati M.H., Mohite H., et al. Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 360 9330 (2002) 374-379
3. Chappuis F., Sundar S., Hailu A., et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?. Nat Rev Microbiol 5 11 (2007) 873-882
4. Duprey Z.H., Steurer F.J., Rooney J.A., et al. Canine visceral leishmaniasis, United States and Canada, 2000-2003. Emerg Infect Dis 12 3 (2006) 440-446
5. Schantz P.M., Steurer F.J., Duprey Z.H., et al. Autochthonous visceral leishmaniasis in dogs in North America. J Am Vet Med Assoc 226 8 (2005) 1316-1322
6. Mancianti F., Gramiccia M., Gradoni L., et al. Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment. Trans R Soc Trop Med Hyg 82 4 (1988) 566-567
7. Travi B.L., Ferro C., Cadena H., et al. Canine visceral leishmaniasis: dog infectivity to sand flies from non-endemic areas. Res Vet Sci 72 1 (2002) 83-86
8. Gaskin A.A., Schantz P., Jackson J., et al. Visceral leishmaniasis in a New York foxhound kennel. J Vet Intern Med 16 1 (2002) 34-44
9. Rosypal A.C., Troy G.C., Duncan R.B., et al. Utility of diagnostic tests used in diagnosis of infection in dogs experimentally inoculated with a North American isolate of Leishmania infantum. J Vet Intern Med 19 6 (2005) 802-809
10. Gibson-Corley K.N., Hostetter J.M., Hostetter S.J., et al. Disseminated Leishmania infantum infection in two sibling American Foxhound dogs from potential vertical transmission. Can Vet J 49 (2008) 1005-1008
11. Owens S.D., Oakley D.A., Marryott K., et al. Transmission of visceral leishmaniasis through blood transfusions from infected English foxhounds to anemic dogs. J Am Vet Med Assoc 219 8 (2001) 1076-1083
12. Maroli M., Mizzon V., Siragusa C., et al. Evidence for an impact on the incidence of canine leishmaniasis by the mass use of deltamethrin-impregnated dog collars in southern Italy. Med Vet Entomol 15 4 (2001) 358-363
13. Quinnell R.J., Courtenay O., Garcez L.M., et al. IgG subclass responses in a longitudinal study of canine visceral leishmaniasis. Vet Immunol Immunopathol 91 3-4 (2003) 161-168
14. Sacks D.L., Lal S.L., Shrivastava S.N., et al. An analysis of T cell responsiveness in Indian kala-azar. J Immunol 138 3 (1987) 908-913
15. Nylen S., Maurya R., Eidsmo L., et al. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med 204 4 (2007) 805-817
16. Nylen S., and Sacks D. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 28 9 (2007) 378-384
17. Blackwell J.M., Mohamed H.S., and Ibrahim M.E. Genetics and visceral leishmaniasis in the Sudan: seeking a link. Trends Parasitol 20 6 (2004) 268-274
18. Karplus T.M., Jeronimo S.M., Chang H., et al. Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection. Infect Immun 70 12 (2002) 6919-6925
19. Modiano J.F., Breen M., Burnett R.C., et al. Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk. Cancer Res 65 13 (2005) 5654-5661
20. Miro G., Cardoso L., Pennisi M.G., et al. Canine leishmaniosis-new concepts and insights on an expanding zoonosis: part two. Trends Parasitol 24 8 (2008) 371-377
21. Croft S.L., Sundar S., and Fairlamb A.H. Drug resistance in leishmaniasis. Clin Microbiol Rev 19 1 (2006) 111-126
22. Foglia Manzillo V., Oliva G., Pagano A., et al. Deltamethrin-impregnated collars for the control of canine leishmaniasis: Evaluation of the protective effect and influence on the clinical outcome of Leishmania infection in kenneled stray dogs. Vet Parasitol 142 1-2 (2006) 142-145
23. Ashford D.A., David J.R., Freire M., et al. Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil. Am J Trop Med Hyg 59 1 (1998) 53-57
24. Moreira Jr. E.D., Mendes de Souza V.M., Sreenivasan M., et al. Assessment of an optimized dog-culling program in the dynamics of canine Leishmania transmission. Vet Parasitol 122 4 (2004) 245-252